| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 56,860 | 57,382 | 54,891 | 59,180 | | Cost of Revenue | 30,381 | 28,628 | 25,209 | 29,684 | | | Gross Profit | 26,479 | 28,754 | 29,682 | 29,496 | | | Operating Expenses | | Research Development | 15,370 | 14,358 | 15,066 | 15,459 | | Selling General and Administrative | 18,098 | 17,528 | 18,919 | 19,589 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,989) | (3,132) | (4,303) | (5,552) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 209 | 214 | 190 | 423 | | Earnings Before Interest And Taxes | (6,780) | (2,918) | (4,113) | (5,129) | | Interest Expense | (87) |
-
|
-
| 278 | | Income Before Tax | (6,693) | (2,918) | (4,113) | (5,407) | | Income Tax Expense | (24) | 19 | 16 | (1,840) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,669) | (2,937) | (4,129) | (3,567) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,669) | (2,937) | (4,129) | (3,567) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,669) | ($2,937) | ($4,129) | ($3,567) |
|
0.51% Nasdaq 
Income Statement
